US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.6096

+0.01372.30%

Volume:130.86K

Turnover:77.80K

Market Cap:24.08M

PE:-0.32

High:0.6188

Open:0.6000

Low:0.5851

Close:0.5959

52wk High:5.14

52wk Low:0.4300

Shares:39.50M

Float Shares:30.75M

Volume Ratio:0.45

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9003

EPS(LYR):-1.6652

ROE:-101.55%

ROA:-55.53%

PB:0.47

PE(LYR):-0.37

Loading ...

Overview Company News Filings

VistaGen says FDA clears refisolone IND to proceed with Phase 2 studies

AbCellera target is profile more attractive than Vistagen, says JonesResearch

VistaGen says FDA clears Phase 2 refisolone study for menopausal hot flashes

Vistagen Receives FDA “Study May Proceed” Letter Under Its Refisolone Ind Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) Due to Menopause

THOMSON REUTERS

Vistagen Therapeutics Inc - FDA Letter Enables Further Phase 2 Development of Refisolone in the U.S.

THOMSON REUTERS

VistaGen Therapeutics Grants Broad Employee Retention Stock Options

VistaGen grants retention stock options to executives at $0.54 per share

VistaGen flags Nasdaq noncompliance after audit committee falls below three members

VistaGen director Mary Rotunno resigns effective April 1, 2026

Class action lawsuit targets VistaGen over alleged misleading fasedienol trial statements

BUZZ-Vistagen cuts 20% of staff to extend cash runway, shares fall

Class action lawsuit targets VistaGen Therapeutics over alleged misleading clinical trial statements

BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction

VistaGen Therapeutics implements 20% workforce reduction

Vistagen Therapeutics Inc - Affected Employees May Receive Cash Severance and Temporary Healthcare Coverage - SEC Filing

THOMSON REUTERS

Vistagen Therapeutics Inc - Expects Costs From Workforce Reduction to Be Immaterial - SEC Filing

THOMSON REUTERS

Class Action Lawsuit Targets VistaGen Therapeutics Over Misleading Trial Claims

Pomerantz Files Securities Class Action Against VistaGen Therapeutics

VistaGen to Participate in Leerink Healthcare Conference and Stifel 2026 Virtual CNS Forum

Schall Law Firm Files Securities Fraud Class Action Against VistaGen Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VTGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics","latestPrice":0.6096,"timestamp":1777569519613,"preClose":0.5959,"halted":0,"volume":130856,"delay":0,"changeRate":0.022990434636684084,"floatShares":30750300,"shares":39495451,"eps":-1.900316,"marketStatus":"Trading","change":0.0137,"latestTime":"04-30 13:18:49 EDT","open":0.6,"high":0.6188,"low":0.5851,"amount":77797.85693679999,"amplitude":0.056553,"askPrice":0.6163,"askSize":10,"bidPrice":0.6028,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-1.900316,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777579200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":0.5959,"preHourTrading":{"tag":"盘前","latestPrice":0.5998,"preClose":0.5959,"latestTime":"09:28 EDT","volume":5447,"amount":3279.6225224100003,"timestamp":1777555705926,"change":0.0039,"changeRate":0.006545,"amplitude":0.017117},"postHourTrading":{"tag":"盘后","latestPrice":0.5855,"preClose":0.5959,"latestTime":"19:42 EDT","volume":2882,"amount":1685.2345,"timestamp":1777506144499,"change":-0.0104,"changeRate":-0.017453,"amplitude":0.01997},"volumeRatio":0.452734,"impliedVol":1.3874,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","floatShares":30750300,"roa":"-55.53%","roe":"-101.55%","lyrEps":-1.66525,"volumeRatio":0.452734,"shares":39495451,"dividePrice":0,"high":0.6188,"amplitude":0.056553,"preClose":0.5959,"low":0.5851,"week52Low":0.43,"pbRate":"0.47","psRate":"30.52","week52High":5.14,"institutionHeld":0,"latestPrice":0.6096,"committee":0.967213,"eps":-1.900316,"divideRate":0,"volume":130856,"delay":0,"ttmEps":-1.900316,"open":0.6,"prevYearClose":0.6619,"prevWeekClose":0.5939,"prevMonthClose":0.5715,"prevQuarterClose":0.5715,"fiveDayClose":0.57,"twentyDayClose":0.6006,"sixtyDayClose":0.5436},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-12","symbol":"VTGN","fiscalQuarterEnding":"2025/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770872400000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2025-11-13","symbol":"VTGN","fiscalQuarterEnding":"2025/09","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2025-08-07","symbol":"VTGN","fiscalQuarterEnding":"2025/06","expectedEps":-0.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-06-17","symbol":"VTGN","fiscalQuarterEnding":"2025/03","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1750132800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2025-02-13","symbol":"VTGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":5,"updateTime":1766030400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VTGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VTGN","date":"2026-04-29","current":-0.313053,"percent":0.938111,"low":-37.785134,"twenty":-6.779962,"median":-2.012696,"eighty":-0.500626,"high":-0.195082,"avg":-5.488031,"sd":8.545112,"marketCap":23637481},"quantilePoints":[{"date":"2021-04-30","current":-32.079325,"twenty":-2.679147,"median":-1.561745,"eighty":-0.742674,"marketCap":480869082},{"date":"2021-05-07","current":-32.586508,"twenty":-2.685764,"median":-1.561745,"eighty":-0.742674,"marketCap":488471755},{"date":"2021-05-14","current":-27.134291,"twenty":-2.72478,"median":-1.583089,"eighty":-0.742674,"marketCap":406743018},{"date":"2021-05-21","current":-35.756402,"twenty":-2.752079,"median":-1.598123,"eighty":-0.742674,"marketCap":535988463},{"date":"2021-05-28","current":-32.8401,"twenty":-2.768658,"median":-1.630931,"eighty":-0.742674,"marketCap":492273092},{"date":"2021-06-04","current":-30.557776,"twenty":-2.77947,"median":-1.651439,"eighty":-0.742674,"marketCap":458061062},{"date":"2021-06-11","current":-35.50281,"twenty":-2.792773,"median":-1.67478,"eighty":-0.742674,"marketCap":532187126},{"date":"2021-06-18","current":-36.643972,"twenty":-2.812661,"median":-1.694545,"eighty":-0.742674,"marketCap":549293141},{"date":"2021-06-25","current":-33.600874,"twenty":-2.818394,"median":-1.70616,"eighty":-0.742823,"marketCap":503677102},{"date":"2021-07-02","current":-36.175919,"twenty":-2.835565,"median":-1.70616,"eighty":-0.742823,"marketCap":648786166},{"date":"2021-07-09","current":-33.081224,"twenty":-2.85862,"median":-1.70616,"eighty":-0.742823,"marketCap":593285285},{"date":"2021-07-16","current":-29.239533,"twenty":-2.885827,"median":-1.70616,"eighty":-0.742823,"marketCap":524387639},{"date":"2021-07-23","current":-30.62681,"twenty":-2.916894,"median":-1.70616,"eighty":-0.742823,"marketCap":549267344},{"date":"2021-07-30","current":-28.492113,"twenty":-2.924134,"median":-1.70616,"eighty":-0.742823,"marketCap":510983246},{"date":"2021-08-06","current":-29.777471,"twenty":-2.938849,"median":-1.715533,"eighty":-0.742823,"marketCap":534035122},{"date":"2021-08-13","current":-23.693959,"twenty":-2.968928,"median":-1.732484,"eighty":-0.743545,"marketCap":534343791},{"date":"2021-08-20","current":-23.009657,"twenty":-3.016018,"median":-1.747566,"eighty":-0.760103,"marketCap":518911480},{"date":"2021-08-27","current":-26.089016,"twenty":-3.058487,"median":-1.763279,"eighty":-0.772114,"marketCap":588356882},{"date":"2021-09-03","current":-27.029931,"twenty":-3.093037,"median":-1.773644,"eighty":-0.779499,"marketCap":609576311},{"date":"2021-09-10","current":-25.832403,"twenty":-3.133777,"median":-1.781251,"eighty":-0.779499,"marketCap":582569765},{"date":"2021-09-17","current":-25.490252,"twenty":-3.173766,"median":-1.800291,"eighty":-0.779499,"marketCap":574853610},{"date":"2021-09-24","current":-24.207185,"twenty":-3.204832,"median":-1.822788,"eighty":-0.779499,"marketCap":545918025},{"date":"2021-10-01","current":-23.009657,"twenty":-3.282133,"median":-1.835745,"eighty":-0.779499,"marketCap":518911480},{"date":"2021-10-08","current":-21.555515,"twenty":-3.313145,"median":-1.858529,"eighty":-0.779499,"marketCap":486117817},{"date":"2021-10-15","current":-20.443524,"twenty":-3.350636,"median":-1.873762,"eighty":-0.779499,"marketCap":461040311},{"date":"2021-10-22","current":-19.759222,"twenty":-3.375442,"median":-1.904318,"eighty":-0.779499,"marketCap":445607999},{"date":"2021-10-29","current":-19.588146,"twenty":-3.418203,"median":-1.917993,"eighty":-0.779499,"marketCap":441749921},{"date":"2021-11-05","current":-21.127826,"twenty":-3.45338,"median":-1.936117,"eighty":-0.779578,"marketCap":476472623},{"date":"2021-11-12","current":-13.833383,"twenty":-3.484535,"median":-1.960234,"eighty":-0.80279,"marketCap":443339179},{"date":"2021-11-19","current":-13.646446,"twenty":-3.554592,"median":-1.974573,"eighty":-0.825259,"marketCap":437348109},{"date":"2021-11-26","current":-12.150945,"twenty":-3.639335,"median":-1.987522,"eighty":-0.828653,"marketCap":389419549},{"date":"2021-12-03","current":-10.406194,"twenty":-3.687422,"median":-2.014852,"eighty":-0.83885,"marketCap":333502896},{"date":"2021-12-10","current":-11.465507,"twenty":-3.752188,"median":-2.030447,"eighty":-0.842198,"marketCap":367452292},{"date":"2021-12-17","current":-11.777069,"twenty":-7.994202,"median":-2.037895,"eighty":-0.845526,"marketCap":377437409},{"date":"2021-12-23","current":-12.649445,"twenty":-11.091631,"median":-2.047717,"eighty":-0.849351,"marketCap":405395735},{"date":"2021-12-31","current":-12.150945,"twenty":-11.492175,"median":-2.058463,"eighty":-0.853568,"marketCap":389419549},{"date":"2022-01-07","current":-10.967006,"twenty":-11.590132,"median":-2.071065,"eighty":-0.859381,"marketCap":351476106},{"date":"2022-01-14","current":-10.842381,"twenty":-11.590132,"median":-2.072974,"eighty":-0.867858,"marketCap":347482059},{"date":"2022-01-21","current":-9.34688,"twenty":-11.590132,"median":-2.080397,"eighty":-0.869049,"marketCap":299553499},{"date":"2022-01-28","current":-9.596131,"twenty":-11.590132,"median":-2.089644,"eighty":-0.874837,"marketCap":307541592},{"date":"2022-02-04","current":-9.34688,"twenty":-11.590132,"median":-2.097879,"eighty":-0.880305,"marketCap":299553499},{"date":"2022-02-11","current":-8.308777,"twenty":-11.590132,"median":-2.106527,"eighty":-0.889608,"marketCap":309791932},{"date":"2022-02-18","current":-7.699467,"twenty":-11.590132,"median":-2.119816,"eighty":-0.895159,"marketCap":287073857},{"date":"2022-02-25","current":-7.754859,"twenty":-11.590132,"median":-2.123135,"eighty":-0.900425,"marketCap":289139137},{"date":"2022-03-04","current":-6.813197,"twenty":-11.590132,"median":-2.131195,"eighty":-0.912803,"marketCap":254029384},{"date":"2022-03-11","current":-6.59163,"twenty":-11.590132,"median":-2.138746,"eighty":-0.928191,"marketCap":245768266},{"date":"2022-03-18","current":-6.813197,"twenty":-11.590132,"median":-2.144456,"eighty":-0.948857,"marketCap":254029384},{"date":"2022-03-25","current":-6.536238,"twenty":-11.590132,"median":-2.154957,"eighty":-0.957849,"marketCap":243702986},{"date":"2022-04-01","current":-6.370063,"twenty":-11.590132,"median":-2.169872,"eighty":-0.963752,"marketCap":237507148},{"date":"2022-04-08","current":-7.533291,"twenty":-11.590132,"median":-2.178195,"eighty":-0.973722,"marketCap":280878018},{"date":"2022-04-14","current":-8.97348,"twenty":-11.590132,"median":-2.185127,"eighty":-0.983853,"marketCap":334575287},{"date":"2022-04-22","current":-7.699467,"twenty":-11.590132,"median":-2.196891,"eighty":-0.995258,"marketCap":287073857},{"date":"2022-04-29","current":-7.034765,"twenty":-11.590132,"median":-2.203547,"eighty":-1.006149,"marketCap":262290502},{"date":"2022-05-06","current":-7.034765,"twenty":-11.590132,"median":-2.215938,"eighty":-1.021031,"marketCap":262290502},{"date":"2022-05-13","current":-6.314671,"twenty":-11.590132,"median":-2.22671,"eighty":-1.027995,"marketCap":235441868},{"date":"2022-05-20","current":-5.816144,"twenty":-11.590132,"median":-2.236341,"eighty":-1.039985,"marketCap":216854352},{"date":"2022-05-27","current":-5.871536,"twenty":-11.590132,"median":-2.249837,"eighty":-1.053264,"marketCap":218919632},{"date":"2022-06-03","current":-6.370063,"twenty":-11.590132,"median":-2.25698,"eighty":-1.079422,"marketCap":237507148},{"date":"2022-06-10","current":-5.539185,"twenty":-11.590132,"median":-2.268657,"eighty":-1.093745,"marketCap":206527955},{"date":"2022-06-17","current":-5.475484,"twenty":-11.590132,"median":-2.28141,"eighty":-1.100513,"marketCap":204152883},{"date":"2022-06-24","current":-4.256347,"twenty":-11.590132,"median":-2.296391,"eighty":-1.115309,"marketCap":203293371},{"date":"2022-07-01","current":-3.773085,"twenty":-11.590132,"median":-2.321872,"eighty":-1.145312,"marketCap":180211576},{"date":"2022-07-08","current":-4.027479,"twenty":-11.590132,"median":-2.324352,"eighty":-1.154027,"marketCap":192362065},{"date":"2022-07-15","current":-3.375053,"twenty":-11.590132,"median":-2.341195,"eighty":-1.170145,"marketCap":161200608},{"date":"2022-07-22","current":-0.648533,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30975479},{"date":"2022-07-29","current":-0.619113,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29570320},{"date":"2022-08-05","current":-0.670165,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32008683},{"date":"2022-08-12","current":-0.544468,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32556040},{"date":"2022-08-19","current":-0.743715,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":44469814},{"date":"2022-08-26","current":-0.656198,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39236854},{"date":"2022-09-02","current":-0.606387,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":36258411},{"date":"2022-09-09","current":-0.715004,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":42753072},{"date":"2022-09-16","current":-0.660695,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39505741},{"date":"2022-09-23","current":-0.56038,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-09-30","current":-0.526135,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":31459808},{"date":"2022-10-07","current":-0.490506,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29329393},{"date":"2022-10-14","current":-0.38604,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":23082936},{"date":"2022-10-21","current":-0.366323,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":21903968},{"date":"2022-10-28","current":-0.449689,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":26888802},{"date":"2022-11-04","current":-0.428934,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25647781},{"date":"2022-11-11","current":-0.519633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-11-18","current":-0.47633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30715197},{"date":"2022-11-25","current":-0.389404,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25109932},{"date":"2022-12-02","current":-0.434631,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":28026324},{"date":"2022-12-09","current":-0.37529,"twenty":-11.590132,"median":-2.359022,"eighty":-1.172623,"marketCap":24199852},{"date":"2022-12-16","current":-0.471519,"twenty":-11.590132,"median":-2.359022,"eighty":-1.16627,"marketCap":30404942},{"date":"2022-12-23","current":-0.313384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.150476,"marketCap":20207910},{"date":"2022-12-30","current":-0.330384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.132526,"marketCap":21304143},{"date":"2023-01-06","current":-0.521557,"twenty":-11.590132,"median":-2.359022,"eighty":-1.111492,"marketCap":33631589},{"date":"2023-01-13","current":-0.513218,"twenty":-11.590132,"median":-2.359022,"eighty":-1.099507,"marketCap":33093815},{"date":"2023-01-20","current":-0.549143,"twenty":-11.590132,"median":-2.359022,"eighty":-1.093055,"marketCap":35410382},{"date":"2023-01-27","current":-0.679693,"twenty":-11.590132,"median":-2.341195,"eighty":-1.07824,"marketCap":43828621},{"date":"2023-02-03","current":-0.962283,"twenty":-11.590132,"median":-2.341031,"eighty":-1.04899,"marketCap":62050903},{"date":"2023-02-10","current":-0.620017,"twenty":-11.590132,"median":-2.341031,"eighty":-1.039212,"marketCap":39500707},{"date":"2023-02-17","current":-0.677853,"twenty":-11.590132,"median":-2.341031,"eighty":-1.026755,"marketCap":43185392},{"date":"2023-02-24","current":-0.614509,"twenty":-11.590132,"median":-2.341031,"eighty":-1.020438,"marketCap":39149784},{"date":"2023-03-03","current":-0.584213,"twenty":-11.590132,"median":-2.341031,"eighty":-1.006123,"marketCap":37219711},{"date":"2023-03-10","current":-0.461656,"twenty":-11.590132,"median":-2.324352,"eighty":-0.995052,"marketCap":29411687},{"date":"2023-03-17","current":-0.475426,"twenty":-11.590132,"median":-2.324352,"eighty":-0.983843,"marketCap":30288982},{"date":"2023-03-24","current":-0.47818,"twenty":-11.590132,"median":-2.324352,"eighty":-0.969566,"marketCap":30464443},{"date":"2023-03-31","current":-0.429295,"twenty":-11.590132,"median":-2.323112,"eighty":-0.962219,"marketCap":27350007},{"date":"2023-04-06","current":-0.456836,"twenty":-11.590132,"median":-2.323112,"eighty":-0.957849,"marketCap":29104619},{"date":"2023-04-14","current":-0.479902,"twenty":-11.590132,"median":-2.324352,"eighty":-0.948422,"marketCap":30574106},{"date":"2023-04-21","current":-0.486098,"twenty":-11.590132,"median":-2.324352,"eighty":-0.920451,"marketCap":30968894},{"date":"2023-04-28","current":-0.470607,"twenty":-11.590132,"median":-2.324352,"eighty":-0.896953,"marketCap":29981925},{"date":"2023-05-05","current":-0.432394,"twenty":-11.590132,"median":-2.324352,"eighty":-0.887332,"marketCap":27547401},{"date":"2023-05-12","current":-0.493328,"twenty":-11.590132,"median":-2.324352,"eighty":-0.868084,"marketCap":31429479},{"date":"2023-05-19","current":-0.48782,"twenty":-11.590132,"median":-2.324352,"eighty":-0.858687,"marketCap":31078557},{"date":"2023-05-26","current":-0.454771,"twenty":-11.590132,"median":-2.321872,"eighty":-0.847383,"marketCap":28973023},{"date":"2023-06-02","current":-0.486098,"twenty":-11.590132,"median":-2.296391,"eighty":-0.842823,"marketCap":30968894},{"date":"2023-06-09","current":-0.290328,"twenty":-11.590132,"median":-2.281329,"eighty":-0.831263,"marketCap":18496511},{"date":"2023-06-16","current":-0.238688,"twenty":-11.590132,"median":-2.262443,"eighty":-0.82638,"marketCap":15206617},{"date":"2023-06-23","current":-0.200819,"twenty":-11.590132,"median":-2.248215,"eighty":-0.803176,"marketCap":12794029},{"date":"2023-06-30","current":-0.239173,"twenty":-11.590132,"median":-2.248215,"eighty":-0.790862,"marketCap":14170462},{"date":"2023-07-07","current":-0.265748,"twenty":-11.590132,"median":-2.239504,"eighty":-0.779697,"marketCap":15744958},{"date":"2023-07-14","current":-0.239173,"twenty":-11.590132,"median":-2.233935,"eighty":-0.766212,"marketCap":14170462},{"date":"2023-07-21","current":-0.248474,"twenty":-11.590132,"median":-2.228997,"eighty":-0.754142,"marketCap":14721535},{"date":"2023-07-28","current":-0.223228,"twenty":-11.590132,"median":-2.228997,"eighty":-0.724814,"marketCap":13225764},{"date":"2023-08-04","current":-0.229111,"twenty":-11.590132,"median":-2.228997,"eighty":-0.710284,"marketCap":13574287},{"date":"2023-08-11","current":-1.293951,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":60006335},{"date":"2023-08-18","current":-1.117918,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":51842887},{"date":"2023-08-25","current":-1.121954,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":52030046},{"date":"2023-09-01","current":-1.075542,"twenty":-11.590132,"median":-2.20645,"eighty":-0.708289,"marketCap":49877724},{"date":"2023-09-08","current":-1.32778,"twenty":-11.590132,"median":-2.204979,"eighty":-0.708289,"marketCap":61575126},{"date":"2023-09-15","current":-1.24101,"twenty":-11.590132,"median":-2.191847,"eighty":-0.708289,"marketCap":57551220},{"date":"2023-09-22","current":-1.03922,"twenty":-11.590132,"median":-2.171822,"eighty":-0.708289,"marketCap":48193298},{"date":"2023-09-29","current":-1.045273,"twenty":-11.590132,"median":-2.122085,"eighty":-0.708289,"marketCap":48474035},{"date":"2023-10-06","current":-1.636861,"twenty":-11.590132,"median":-2.080397,"eighty":-0.708289,"marketCap":75908600},{"date":"2023-10-13","current":-1.760348,"twenty":-11.590132,"median":-2.052187,"eighty":-0.708289,"marketCap":81635252},{"date":"2023-10-20","current":-1.581686,"twenty":-11.590132,"median":-2.0251,"eighty":-0.708289,"marketCap":73349883},{"date":"2023-10-23","current":-1.565921,"twenty":-11.590132,"median":-2.024672,"eighty":-0.708289,"marketCap":72618821},{"date":"2023-11-03","current":-1.723564,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":79929440},{"date":"2023-11-10","current":-1.684041,"twenty":-11.590132,"median":-1.950372,"eighty":-0.702187,"marketCap":78096579},{"date":"2023-11-17","current":-2.528721,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":89716486},{"date":"2023-11-24","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-01","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-08","current":-3.709298,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":131602195},{"date":"2023-12-15","current":-3.777848,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":134034268},{"date":"2023-12-22","current":-3.884481,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":137817493},{"date":"2023-12-29","current":-3.991114,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":141600719},{"date":"2024-01-05","current":-3.876864,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":137547263},{"date":"2024-01-12","current":-4.151063,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":147275557},{"date":"2024-01-19","current":-3.655982,"twenty":-11.590132,"median":-1.925948,"eighty":-0.698735,"marketCap":129710582},{"date":"2024-01-26","current":-3.671215,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":130251043},{"date":"2024-02-02","current":-3.655982,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":129710582},{"date":"2024-02-09","current":-3.770231,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":133764038},{"date":"2024-02-16","current":-4.567745,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":146476632},{"date":"2024-02-23","current":-4.146367,"twenty":-11.590132,"median":-1.962469,"eighty":-0.700461,"marketCap":132964028},{"date":"2024-03-01","current":-4.306491,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":138098817},{"date":"2024-03-08","current":-3.569078,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":114451760},{"date":"2024-03-15","current":-3.303609,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":105938819},{"date":"2024-03-22","current":-3.552223,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":113911255},{"date":"2024-03-28","current":-3.851402,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":123505205},{"date":"2024-04-05","current":-4.458187,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":142963355},{"date":"2024-04-12","current":-4.470828,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":143368733},{"date":"2024-04-19","current":-3.96096,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":127018482},{"date":"2024-04-26","current":-3.96096,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":127018482},{"date":"2024-05-03","current":-3.71656,"twenty":-11.590132,"median":-2.022834,"eighty":-0.702187,"marketCap":119181171},{"date":"2024-05-10","current":-3.775553,"twenty":-11.590132,"median":-2.06822,"eighty":-0.702187,"marketCap":121072936},{"date":"2024-05-17","current":-3.834546,"twenty":-11.590132,"median":-2.260612,"eighty":-0.702187,"marketCap":122964700},{"date":"2024-05-24","current":-3.455306,"twenty":-11.590132,"median":-2.481343,"eighty":-0.702187,"marketCap":110803356},{"date":"2024-05-31","current":-3.278327,"twenty":-11.590132,"median":-2.528721,"eighty":-0.702187,"marketCap":105128063},{"date":"2024-06-07","current":-3.253044,"twenty":-11.590132,"median":-2.569513,"eighty":-0.702187,"marketCap":104317306},{"date":"2024-06-14","current":-3.239859,"twenty":-11.590132,"median":-2.650451,"eighty":-0.700461,"marketCap":95128735},{"date":"2024-06-21","current":-2.963734,"twenty":-11.590132,"median":-2.695417,"eighty":-0.698735,"marketCap":87021172},{"date":"2024-06-28","current":-3.203042,"twenty":-11.590132,"median":-2.73437,"eighty":-0.693557,"marketCap":94047727},{"date":"2024-07-05","current":-3.046572,"twenty":-11.590132,"median":-2.762551,"eighty":-0.693557,"marketCap":89453441},{"date":"2024-07-12","current":-3.59882,"twenty":-11.590132,"median":-2.788793,"eighty":-0.693557,"marketCap":105668567},{"date":"2024-07-15","current":-3.534391,"twenty":-11.590132,"median":-2.795067,"eighty":-0.693557,"marketCap":103776802},{"date":"2024-08-02","current":-3.100103,"twenty":-11.814457,"median":-2.833386,"eighty":-0.682688,"marketCap":91025218},{"date":"2024-08-09","current":-3.14156,"twenty":-11.814457,"median":-2.87737,"eighty":-0.682688,"marketCap":92242494},{"date":"2024-08-16","current":-2.755069,"twenty":-11.814457,"median":-2.894519,"eighty":-0.682688,"marketCap":91446261},{"date":"2024-08-23","current":-2.975149,"twenty":-11.814457,"median":-2.918362,"eighty":-0.682688,"marketCap":98751140},{"date":"2024-08-30","current":-2.869185,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":95233976},{"date":"2024-09-06","current":-2.657256,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":88199648},{"date":"2024-09-13","current":-2.600199,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":86305791},{"date":"2024-09-20","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-09-27","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-10-04","current":-2.404572,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":79812565},{"date":"2024-10-11","current":-2.46163,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81706423},{"date":"2024-10-18","current":-2.494234,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":82788627},{"date":"2024-10-25","current":-2.469781,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81976974},{"date":"2024-10-31","current":-2.518688,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":83600280},{"date":"2024-11-08","current":-2.543141,"twenty":-11.826919,"median":-2.927982,"eighty":-0.68268,"marketCap":84411933},{"date":"2024-11-15","current":-1.866798,"twenty":-11.826919,"median":-2.927982,"eighty":-0.684226,"marketCap":73860442},{"date":"2024-11-22","current":-1.780462,"twenty":-11.826919,"median":-2.927982,"eighty":-0.711322,"marketCap":70443968},{"date":"2024-11-29","current":-1.998621,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":79075443},{"date":"2024-12-06","current":-1.826205,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72253794},{"date":"2024-12-13","current":-1.745275,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":69051795},{"date":"2024-12-20","current":-1.583415,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":62647798},{"date":"2024-12-27","current":-1.829724,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72393011},{"date":"2025-01-03","current":-2.332897,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":92301089},{"date":"2025-01-10","current":-2.132332,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":84365701},{"date":"2025-01-17","current":-2.05492,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81302920},{"date":"2025-01-24","current":-2.090107,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82695094},{"date":"2025-01-31","current":-2.068995,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81859790},{"date":"2025-02-07","current":-2.019733,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":79910747},{"date":"2025-02-14","current":-1.738893,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82256942},{"date":"2025-02-21","current":-1.751103,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82834183},{"date":"2025-02-28","current":-1.549757,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":73309695},{"date":"2025-03-07","current":-1.629075,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":77061766},{"date":"2025-03-14","current":-1.659582,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":78504871},{"date":"2025-03-21","current":-1.690089,"twenty":-11.851844,"median":-2.928824,"eighty":-0.732399,"marketCap":79947975},{"date":"2025-03-28","current":-1.604669,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":75907283},{"date":"2025-04-04","current":-1.39112,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":65805553},{"date":"2025-04-11","current":-1.250788,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59167274},{"date":"2025-04-17","current":-1.262991,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59744515},{"date":"2025-04-25","current":-1.427729,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":67537278},{"date":"2025-05-02","current":-1.439932,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68114520},{"date":"2025-05-09","current":-1.372816,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":64939691},{"date":"2025-05-16","current":-1.403323,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66382795},{"date":"2025-05-23","current":-1.482641,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":70134866},{"date":"2025-05-30","current":-1.555858,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":73598316},{"date":"2025-06-06","current":-1.446033,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68403141},{"date":"2025-06-13","current":-1.412475,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66815726},{"date":"2025-06-20","current":-1.168169,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":60064929},{"date":"2025-06-27","current":-1.162499,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":59773352},{"date":"2025-07-03","current":-1.134145,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":58315466},{"date":"2025-07-11","current":-1.377986,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":70853291},{"date":"2025-07-18","current":-1.440364,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":74060641},{"date":"2025-07-25","current":-1.536766,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":79017456},{"date":"2025-08-01","current":-1.627498,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":83682693},{"date":"2025-08-08","current":-1.585392,"twenty":-11.864307,"median":-2.927982,"eighty":-0.737322,"marketCap":81517693},{"date":"2025-08-15","current":-1.625328,"twenty":-11.864307,"median":-2.915434,"eighty":-0.737322,"marketCap":90660791},{"date":"2025-08-22","current":-1.683081,"twenty":-11.864307,"median":-2.877336,"eighty":-0.737322,"marketCap":93882241},{"date":"2025-08-29","current":-1.776585,"twenty":-11.864307,"median":-2.863852,"eighty":-0.737322,"marketCap":99097921},{"date":"2025-09-05","current":-1.991095,"twenty":-11.876769,"median":-2.857435,"eighty":-0.736288,"marketCap":111063305},{"date":"2025-09-12","current":-1.925092,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":107381648},{"date":"2025-09-19","current":-1.67208,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":93268631},{"date":"2025-09-26","current":-1.853589,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":103393187},{"date":"2025-10-03","current":-1.980095,"twenty":-11.864307,"median":-2.83596,"eighty":-0.737322,"marketCap":110449695},{"date":"2025-10-10","current":-2.315611,"twenty":-11.864307,"median":-2.802915,"eighty":-0.737322,"marketCap":129164782},{"date":"2025-10-17","current":-2.227607,"twenty":-11.864307,"median":-2.73437,"eighty":-0.737322,"marketCap":124255907},{"date":"2025-10-24","current":-2.28811,"twenty":-11.864307,"median":-2.673112,"eighty":-0.737322,"marketCap":127630759},{"date":"2025-10-31","current":-2.062599,"twenty":-11.864307,"median":-2.649105,"eighty":-0.737322,"marketCap":115051766},{"date":"2025-11-07","current":-2.211106,"twenty":-11.864307,"median":-2.567594,"eighty":-0.737322,"marketCap":123335493},{"date":"2025-11-14","current":-2.0901,"twenty":-11.864307,"median":-2.53499,"eighty":-0.737322,"marketCap":116585789},{"date":"2025-11-21","current":-2.824005,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":175754756},{"date":"2025-11-28","current":-3.109578,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":193527709},{"date":"2025-12-05","current":-2.716121,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":169040530},{"date":"2025-12-12","current":-2.506701,"twenty":-11.864307,"median":-2.518688,"eighty":-0.737322,"marketCap":156007031},{"date":"2025-12-19","current":-0.46961,"twenty":-11.801994,"median":-2.505871,"eighty":-0.722332,"marketCap":29226633},{"date":"2025-12-26","current":-0.461931,"twenty":-11.590132,"median":-2.494234,"eighty":-0.710167,"marketCap":28748738},{"date":"2026-01-02","current":-0.420047,"twenty":-11.390732,"median":-2.469781,"eighty":-0.68148,"marketCap":26142039},{"date":"2026-01-09","current":-0.446637,"twenty":-11.216257,"median":-2.464118,"eighty":-0.673408,"marketCap":27796898},{"date":"2026-01-16","current":-0.425822,"twenty":-10.967006,"median":-2.453479,"eighty":-0.659291,"marketCap":26501447},{"date":"2026-01-23","current":-0.420555,"twenty":-10.431119,"median":-2.445328,"eighty":-0.65328,"marketCap":26173635},{"date":"2026-01-30","current":-0.34345,"twenty":-10.119556,"median":-2.404572,"eighty":-0.642171,"marketCap":21374938},{"date":"2026-02-06","current":-0.320477,"twenty":-9.795531,"median":-2.350491,"eighty":-0.624554,"marketCap":19945202},{"date":"2026-02-13","current":-0.345861,"twenty":-9.421655,"median":-2.315611,"eighty":-0.614743,"marketCap":21525020},{"date":"2026-02-20","current":-0.350015,"twenty":-9.12284,"median":-2.255108,"eighty":-0.605072,"marketCap":23467113},{"date":"2026-02-27","current":-0.35752,"twenty":-8.530345,"median":-2.227607,"eighty":-0.589095,"marketCap":23970291},{"date":"2026-03-06","current":-0.363016,"twenty":-8.242307,"median":-2.211106,"eighty":-0.576686,"marketCap":24338760},{"date":"2026-03-13","current":-0.372766,"twenty":-7.777016,"median":-2.194605,"eighty":-0.562871,"marketCap":24992495},{"date":"2026-03-20","current":-0.379562,"twenty":-7.699467,"median":-2.167104,"eighty":-0.554569,"marketCap":25448129},{"date":"2026-03-27","current":-0.357402,"twenty":-7.533291,"median":-2.132332,"eighty":-0.544676,"marketCap":23962367},{"date":"2026-04-02","current":-0.35492,"twenty":-7.333881,"median":-2.090107,"eighty":-0.536314,"marketCap":23795962},{"date":"2026-04-10","current":-0.328505,"twenty":-7.090157,"median":-2.076032,"eighty":-0.525611,"marketCap":22024934},{"date":"2026-04-17","current":-0.356397,"twenty":-7.034765,"median":-2.061958,"eighty":-0.517151,"marketCap":23895013},{"date":"2026-04-24","current":-0.336837,"twenty":-6.835354,"median":-2.029597,"eighty":-0.503917,"marketCap":22583580},{"date":"2026-04-29","current":-0.352556,"twenty":-6.779962,"median":-2.012696,"eighty":-0.500626,"marketCap":23637481}],"updateTime":1777564125234},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631364505","title":"VistaGen says FDA clears refisolone IND to proceed with Phase 2 studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2631364505","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631364505?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:38","pubTimestamp":1777408721,"startTime":"0","endTime":"0","summary":"VistaGen received an FDA “Study May Proceed” letter under its IND for refisolone nasal spray, clearing further Phase 2 development in the US for menopausal hot flashes.Refisolone is positioned as a non-hormonal, non-systemic treatment targeting moderate to severe vasomotor symptoms due to menopause.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL9cgmnY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629028466","title":"AbCellera target is profile more attractive than Vistagen, says JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2629028466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629028466?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:45","pubTimestamp":1776869136,"startTime":"0","endTime":"0","summary":"JonesResearch notes that Vistagen (VTGN) received an FDA “Study May Proceed” letter enabling further Phase 2 development of intranasal refisolone f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-target-is-profile-more-attractive-than-vistagen-says-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-target-is-profile-more-attractive-than-vistagen-says-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","VTGN","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629495540","title":"VistaGen says FDA clears Phase 2 refisolone study for menopausal hot flashes","url":"https://stock-news.laohu8.com/highlight/detail?id=2629495540","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629495540?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:32","pubTimestamp":1776861142,"startTime":"0","endTime":"0","summary":"VistaGen received an FDA “Study May Proceed” letter under its IND for refisolone nasal spray, clearing further Phase 2 development in US for menopausal hot flashes.Phase 2a data cited hot flash frequency fell 80% with refisolone versus 36% with placebo in a 36-patient study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL9Sgs5y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629493680","title":"Vistagen Receives FDA “Study May Proceed” Letter Under Its Refisolone Ind Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) Due to Menopause","url":"https://stock-news.laohu8.com/highlight/detail?id=2629493680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629493680?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:30","pubTimestamp":1776861001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA6HL0BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629049334","title":"Vistagen Therapeutics Inc - FDA Letter Enables Further Phase 2 Development of Refisolone in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629049334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629049334?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:30","pubTimestamp":1776861001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA6HL0BN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627469666","title":"VistaGen Therapeutics Grants Broad Employee Retention Stock Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2627469666","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627469666?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:50","pubTimestamp":1776117000,"startTime":"0","endTime":"0","summary":"An announcement from VistaGen Therapeutics ( ($VTGN) ) is now available. On April 7, 2026, Vistagen Therapeutics’ compensation committee approved b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vistagen-therapeutics-grants-broad-employee-retention-stock-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vistagen-therapeutics-grants-broad-employee-retention-stock-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627781466","title":"VistaGen grants retention stock options to executives at $0.54 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2627781466","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627781466?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:28","pubTimestamp":1776115711,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics set retention stock option awards for all employees on April 7, 2026.Each of five named executives received options for up to 75,000 shares.Options carry exercise price of $0.54 per share.Vesting starts with 25% at six months from grant date.Remaining vesting occurs in 25% installments every six months, reaching full vesting at two years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL8lwRpn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509682","title":"VistaGen flags Nasdaq noncompliance after audit committee falls below three members","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624509682?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:18","pubTimestamp":1775161108,"startTime":"0","endTime":"0","summary":"VistaGen notified Nasdaq on April 1, 2026, that it is out of compliance with listing rule requiring at least three independent audit committee members.Nasdaq listing of VistaGen common stock remains unchanged while company uses cure period to regain compliance.Board plans to restore compliance before cure period expires.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL6Cbh8c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620417267","title":"VistaGen director Mary Rotunno resigns effective April 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620417267","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620417267?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:46","pubTimestamp":1773866789,"startTime":"0","endTime":"0","summary":"Mary Rotunno resigned from VistaGen’s board of directors, effective April 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8rBffv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619703158","title":"Class action lawsuit targets VistaGen over alleged misleading fasedienol trial statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2619703158","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619703158?lang=en_us&edition=fundamental","pubTime":"2026-03-13 00:01","pubTimestamp":1773331285,"startTime":"0","endTime":"0","summary":"A securities class action has been filed against VistaGen and certain officers on behalf of investors who purchased or acquired its securities between April 1, 2024 and December 16, 2025. The complaint alleges the defendants made materially false or misleading statements about the development and prospects of fasedienol, an investigational treatment for social anxiety disorder. It also alleges the company disseminated false or misleading information or concealed material adverse data regarding the design, execution, and results of the Phase 3 PALISADE-3 trial. More information is posted at bgandg.com/VTGN.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDLcDrjw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","BK4139","IE00B3QW5Z07.USD","SG9999014013.SGD","LU0314104364.USD","SG9999014021.USD","LU2210149790.SGD","IE00B64PRP62.GBP","LU2095319765.USD","BK4585","BK4112","NDAQ","SG9999014039.USD","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618940941","title":"BUZZ-Vistagen cuts 20% of staff to extend cash runway, shares fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940941","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940941?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:10","pubTimestamp":1773234628,"startTime":"0","endTime":"0","summary":"BUZZ-Vistagen cuts 20% of staff to extend cash runway, shares fall** Shares of drug developer Vistagen Therapeutics VTGN.O falls 3% to $0.60 premarket ** Co says it cut 20% of its workforce on March 5 to manage cash and support its Palisade program clinical studies** Expects cash runway to now extend into 2027** Palisade program includes studies of its experimental nasal spray for mental health conditions, aiming to offer faster-acting treatment options - VTGN** Co says the job cuts will have immaterial costs and affected employees may receive cash severance and temporary healthcare coverage** VTGN fell ~66% in 2025","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618940583","title":"Class action lawsuit targets VistaGen Therapeutics over alleged misleading clinical trial statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940583","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940583?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:03","pubTimestamp":1773234200,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against VistaGen on behalf of shareholders who purchased securities between April 1, 2024 and December 16, 2025. The complaint alleges the company made materially misleading statements about its clinical trial program that inflated the stock price. The announcement said the stock suffered substantial losses after the alleged truth emerged.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL5m8pmd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618949224","title":"BRIEF-Vistagen Therapeutics Implements 20% Workforce Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949224","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949224?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:14","pubTimestamp":1773227656,"startTime":"0","endTime":"0","summary":"BRIEF-Vistagen Therapeutics Implements 20% Workforce ReductionMarch 11  - VistaGen Therapeutics Inc VTGN.O:VISTAGEN THERAPEUTICS INC - IMPLEMENTS 20% WORKFORCE REDUCTION ON MARCH 5, 2026 - SEC FILINGVISTAGEN THERAPEUTICS INC - REDUCTION SUPPORTS CASH MANAGEMENT AND PALISADE PROGRAM CLINICAL STUDIES - SEC FILINGVISTAGEN THERAPEUTICS INC - EXPECTS COSTS FROM WORKFORCE REDUCTION TO BE IMMATERIAL - SEC FILINGVISTAGEN THERAPEUTICS INC - EXPECTS CASH RUNWAY INTO 2027 - SEC FILINGVISTAGEN THERAPEUTICS INC - AFFECTED EMPLOYEES MAY RECEIVE CASH SEVERANCE AND TEMPORARY HEALTHCARE COVERAGE - SEC FILINGSource text: [ID:n0001628280-26-016652]Further company coverage: VTGN.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nFWN3ZZ0FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618949690","title":"VistaGen Therapeutics implements 20% workforce reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949690","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949690?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:03","pubTimestamp":1773227013,"startTime":"0","endTime":"0","summary":"VistaGen implemented a board-approved workforce reduction of about 20%. The change is intended to manage cash while prioritizing ongoing clinical studies in its PALISADE program for fasedienol for acute treatment of social anxiety disorder. The company said it expects topline results from the PALISADE-4 Phase 3 trial in the first half of 2026 and expects cash runway into 2027. Affected employees may receive cash severance and temporary healthcare coverage if they sign a separation agreement that includes a general release of claims.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval sy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL9d7S8b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618949192","title":"Vistagen Therapeutics Inc - Affected Employees May Receive Cash Severance and Temporary Healthcare Coverage - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949192","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949192?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:02","pubTimestamp":1773226976,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nFWN3ZZ0FD:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618622949","title":"Vistagen Therapeutics Inc - Expects Costs From Workforce Reduction to Be Immaterial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2618622949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618622949?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:02","pubTimestamp":1773226976,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nFWN3ZZ0FD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617599866","title":"Class Action Lawsuit Targets VistaGen Therapeutics Over Misleading Trial Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2617599866","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617599866?lang=en_us&edition=fundamental","pubTime":"2026-03-05 09:16","pubTimestamp":1772673371,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against VistaGen Therapeutics in the U.S. District Court for the Northern District of California on behalf of investors who purchased or acquired the company’s common stock between April 1, 2024 and December 16, 2025. The complaint alleges the company made materially false or misleading statements and concealed adverse facts about its Phase 3 PALISADE-3 trial of intranasal fasedienol for social anxiety disorder. VistaGen announced on December 17, 2025 that the trial did not meet its primary endpoint, after which the stock fell more than 80% to $0.86 from $4.36, and investors have until March 16, 2026 to seek appointment as lead plaintiff.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL2mWGT7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4112","LU2095319765.USD","LU0314104364.USD","SG9999014021.USD","VTGN","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014039.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4139","NDAQ","SG9999014013.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4588","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616739863","title":"Pomerantz Files Securities Class Action Against VistaGen Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2616739863","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616739863?lang=en_us&edition=fundamental","pubTime":"2026-03-04 02:34","pubTimestamp":1772562852,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against VistaGen Therapeutics in connection with alleged securities fraud and other unlawful business practices. The case follows the company’s December 17, 2025 disclosure that its PALISADE-3 Phase 3 study of intranasal fasedienol for acute treatment of social anxiety disorder failed to meet its primary endpoint, after which VistaGen shares fell about 80% to close at $0.861. Investors who bought or acquired VistaGen securities during the class period have until March 16, 2026 to seek appointment as lead plaintiff.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDLm3P7C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","SG9999014013.SGD","VTGN","IE00BGHQF748.EUR","BK4112","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","IE00BKPKM429.USD","LU2210149790.SGD","BK4585","BK4588","LU2095319765.USD","SG9999014021.USD","SG9999014005.SGD","SG9999014039.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616233173","title":"VistaGen to Participate in Leerink Healthcare Conference and Stifel 2026 Virtual CNS Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2616233173","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616233173?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:30","pubTimestamp":1772544651,"startTime":"0","endTime":"0","summary":"VistaGen to Participate in Leerink Healthcare Conference and Stifel 2026 Virtual CNS Forum               VistaGen Therapeutics Inc. will participate in the Leerink Healthcare Conference in Miami, Flor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL7sfrxz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BK4139","BK7035","VTGN","SF","EVT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616350329","title":"Schall Law Firm Files Securities Fraud Class Action Against VistaGen Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350329","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616350329?lang=en_us&edition=fundamental","pubTime":"2026-03-03 02:06","pubTimestamp":1772474808,"startTime":"0","endTime":"0","summary":"The Schall Law Firm has filed a proposed securities class action against VistaGen Therapeutics Inc. in U.S. court, alleging violations of federal securities laws. The suit claims the company made false and misleading statements about the likelihood of Phase 3 success for its fasedienol drug candidate and created an overly positive impression of results from the PALISADE-2 trial, leading to investor losses when the alleged truth emerged. The case covers investors who bought shares between April 1, 2024 and December 16, 2025, and a lead plaintiff deadline of March 16, 2026 has been set.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL22qCd4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","VTGN","IE00B3QW5Z07.USD","SG9999014021.USD","BK4588","BK4112","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014039.USD","BK4139","LU0314104364.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014005.SGD","BK4585","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}]}}